TLDR
- Veeva Systems surged 20% to $294.54, on pace for its best ever daily percentage gain
- Q2 FY2027 revenue hit $928 million, up 18% year-over-year, beating the $905 million consensus
- Adjusted EPS of $2.35 topped the $2.22 estimate; full-year EPS guidance raised to $9.21
- Subscription revenue grew 16% to $766.8 million; non-GAAP operating margins held above 44%
- Eli Lilly and Biogen joined Vault CRM, bringing top-20 biopharma clients on the platform to 12
Veeva Systems posted its best-ever single-day gain on Thursday, with the stock jumping 20% to $294.54. The move came after the life sciences cloud software company delivered a clean beat across every key metric in its fiscal second quarter of 2027.
Revenue came in at $928 million, up 18% year-over-year and ahead of the $905 million Wall Street had penciled in. Adjusted EPS of $2.35 beat the $2.22 consensus estimate.
Management raised full-year FY2027 revenue guidance to $3.68-$3.69 billion, above the prior analyst consensus of roughly $3.65 billion. Full-year adjusted EPS guidance was lifted to $9.21 from $9.05.
VEEVA SYSTEMS $VEEV Q2’27 EARNINGS HIGHLIGHTS
🔹 Revenue: $928.0M (Est. $905M) 🟢; +18% YoY
🔹 Adj. EPS: $2.35 (Est. $2.22) 🟢; +18% YoY
🔹 Non-GAAP Oper Income: $415.9M (Est. $395M) 🟢; +18% YoY
🔹 Non-GAAP Net Income: $387.4M (Est. $365M) 🟢; +16% YoYFY27 Guide:
🔹 Revenue:…— Wall St Engine (@wallstengine) August 26, 2026
Subscription revenue, Veeva’s most closely watched metric, grew 16% year-over-year to $766.8 million. Non-GAAP operating margins held above 44%, showing that growth is not coming at the expense of profitability.
CEO Peter Gassner said “Vault CRM had its best quarter ever and Veeva Falcon accelerated rapidly,” adding that AI is “opening up the next big chapter for Veeva and life sciences.”
Two additional top-20 biopharma customers, Eli Lilly and Biogen, committed to Vault CRM during the quarter. That brings the total to 12 of the industry’s top 20 firms on the platform.
Nearly 20 analyst firms raised price targets on the stock following the results.
Analyst Reactions
Barclays analyst Saket Kalia raised his price target to $315 from $275, keeping an Overweight rating. He pointed to the acceleration in subscription revenue as an excellent sign of growth.
Piper Sandler initiated coverage at Overweight with a $295 target. Guggenheim raised its target to $310 from $276, keeping a Buy rating, and called Veeva “indispensable for its customers.”
Morgan Stanley analyst Craig Hettenbach raised his target to $275 from $215. He flagged the company’s annual investor day on November 5 as the next key catalyst, calling it “a referendum on the company’s AI strategy.”
Even the skeptics took a step toward the bull camp. Canaccord raised its target to $260 from $220 but kept a Hold rating, calling the quarter one of the “cleanest” in some time.
Broader Market Context
The move did not happen in a vacuum. Salesforce jumped more than 20% the same day, after topping Q2 expectations and expanding its partnership with Anthropic. ServiceNow and Datadog also posted sharp gains.
Nvidia earnings earlier in the week appeared to reignite appetite for tech and software stocks more broadly. The Nasdaq gained 1.1% and the S&P 500 added 0.5% on Thursday.
Veeva was the second-best performer in the S&P 500 on the day, behind Salesforce.
The stock was in pre-market trading at $264, well above its session open of $239.87, before extending gains as the session progressed.
Veeva’s next major event is the annual investor day on November 5, where management is expected to lay out its AI strategy in detail.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
